Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xiaolong Tom Zhang"'
Publikováno v:
AAPS Open, Vol 7, Iss 1, Pp 1-14 (2021)
Abstract Dostarlimab is a humanized anti–PD-1 monoclonal antibody. Dostarlimab (JEMPERLI; TSR-042) was recently approved in the USA and in the EU. The presence of neutralizing antibodies (NAbs) is a cause for concern because they block the therapeu
Externí odkaz:
https://doaj.org/article/9cc562b825a24dee8a7fce5d389aa00c
Bio distribution The evaluation of vector distribution profile following gene therapeutic administration is one of the key components to preclinical and clinical programs [3]. The biodistribution data serves to investigate the presence of vectors in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::bad9a89af872bbafe09c50d2f91f7c0b
https://zenodo.org/record/8157833
https://zenodo.org/record/8157833
Publikováno v:
AAPS Open, Vol 7, Iss 1, Pp 1-14 (2021)
Dostarlimab is a humanized anti–PD-1 monoclonal antibody. Dostarlimab (JEMPERLI; TSR-042) was recently approved in the USA and in the EU. The presence of neutralizing antibodies (NAbs) is a cause for concern because they block the therapeutic funct
Autor:
Jing Shi, Liying Jiang, Xiaoying Jin, Xuesong Chen, Xiaolong Tom Zhang, Yonghui Wang, Stephen Li, Jianbo Diao, Wenzhong Liang, Lan Li, Colton Wong, Francis L S Tse
Publikováno v:
The AAPS Journal
In the absence of regulatory guidelines for the bioanalysis of new drug modalities, many of which contain multiple functional domains, bioanalytical strategies have been carefully designed to characterize the intact drug and each functional domain in